top of page

Dustin Robinson to Host Psychedelic Series with Jay Godfrey and Dr. Scott Fisher

On Monday, Dec. 20 at 7 p.m., Dustin Robinson, Esq. CPA, will present his monthly Psychedelic Series at Soho Beach House Miami. The panel will feature Jay Godfrey, co-founder of Nushama Psychedelic Wellness, and Dr. Scott Fisher, advisory board member of Iter Investments.

Robinson is Founding Partner of Mr. Cannabis Law – a full service law firm focused on the cannabis and psychedelic industries; Co-Founder of Mr. Psychedelic Law – a non-profit focused on psychedelic legal reform; and Managing Principal of Iter Investments – a venture capital firm deploying capital across the psychedelic ecosystem.

Godfrey is a co-founder of Nushama Psychedelic Wellness – a network of legal psychedelic wellness clinics to treat depression, anxiety, PTSD, opioid addictions, alcoholism, OCD, eating disorders and other ailments of the spirit. His fascination and exploration into the therapeutic benefits of plant medicine came with realization that three years of traditional talk therapy was insufficient to get to the root of his stress. After working with physicians, shamans, reading dozens of books and research papers, and talking with thought leaders in the psychedelic ecosystem, he felt the gravitational pull to help others in similar situations. Nushama was born out of Godfrey’s desire to partner with the most experienced physicians and business minds to create novel treatment alternatives and build the infrastructure for the future of psychedelic medicine.

Dr. Fisher is an advisory board member of Iter Investments. He is a psychiatrist and Lead Facilitator at Segal Clinical Trials for the Usona Institute sponsored PSIL201, a study of the effectiveness of a single dose of psilocybin for the treatment of major depressive disorder. He is one of the few licensed psychiatrists in the world who has completed a certificate in psychedelic-assisted psychotherapy at an accredited institution of higher learning, the California Institute of Integral Studies. Dr. Fisher has completed the MAPS Certificate of Training for MDMA-assisted psychotherapy for PTSD. He also has experience offering ketamine-assisted psychotherapy, a form of psychedelic-assisted psychotherapy. He currently serves as a scientific and psychiatric advisor on two different advisory boards for major players in the psychedelic medicine space, offering advice on how psychedelic-assisted psychotherapy is likely to roll out and be used in a medical system that currently is not well-adapted to such a novel and revolutionary form of mental health treatment.

Moderated by Robinson, each private monthly panel features experts in the psychedelics space from CEOs, doctors, lawyers and celebrities. Past panelists include NBA Champion Lamar Odom, Stanley Cup champion Daniel Carcillo, Psilera Bioscience CEO Chris Witowski, PhD, Silo Wellness CEO Douglas K. Gordon, Michelle Weiner, DO, MPH, and others.

bottom of page